1-Methylindole-3-acetic Acid - CAS 1912-48-7
Catalog: |
BB014800 |
Product Name: |
1-Methylindole-3-acetic Acid |
CAS: |
1912-48-7 |
Synonyms: |
2-(1-methyl-3-indolyl)acetic acid; 2-(1-methylindol-3-yl)acetic acid |
IUPAC Name: | 2-(1-methylindol-3-yl)acetic acid |
Description: | 1-Methylindole-3-acetic Acid (CAS# 1912-48-7) is a N-methylated derivative of Indole-3-acetic acid, a natural auxin, with plant growth regulating activity. |
Molecular Weight: | 189.21 |
Molecular Formula: | C11H11NO2 |
Canonical SMILES: | CN1C=C(C2=CC=CC=C21)CC(=O)O |
InChI: | InChI=1S/C11H11NO2/c1-12-7-8(6-11(13)14)9-4-2-3-5-10(9)12/h2-5,7H,6H2,1H3,(H,13,14) |
InChI Key: | NAIPEFIYIQFVFC-UHFFFAOYSA-N |
Boiling Point: | 392 °C at 760 mmHg |
Density: | 1.2 g/cm3 |
MDL: | MFCD00130160 |
LogP: | 1.80540 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111196801-A | Aporphine alkaloid derivative and preparation method and application thereof | 20200114 |
WO-2021066573-A1 | Novel compound and use thereof in treating autoimmune diseases | 20191004 |
KR-20210040803-A | Compounds and pharmaceutical compositions for treating autoimmune diseases | 20191004 |
US-2020352918-A1 | Compounds and methods for treating or preventing fibrosis | 20190507 |
WO-2020084131-A1 | Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same | 20181026 |
PMID | Publication Date | Title | Journal |
17481907 | 20070701 | Binding of ring-substituted indole-3-acetic acids to human serum albumin | Bioorganic & medicinal chemistry |
16141651 | 20050801 | Effect of indole-3-acetic acid derivatives on neuroepithelium in rat embryos | The Journal of toxicological sciences |
12182852 | 20020916 | Halogenated indole-3-acetic acids as oxidatively activated prodrugs with potential for targeted cancer therapy | Bioorganic & medicinal chemistry letters |
Complexity: | 229 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 189.078978594 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 189.078978594 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 42.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[597-35-3]
ethylsulfone
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[1184173-73-6]
MK-8353
-
[52236-30-3]
Metribuzin-desamino-diketo
-
[3886-90-6]
N,N-dimethyloctadecanamide
-
[92-06-8]
m-Terphenyl
INDUSTRY LEADERS TRUST OUR PRODUCTS